Lumida
/ENSG
⌘K
Ensign Group Inc

Ensign Group Inc

ENSG
$179.37USD-0.06%-0.11 today

MARKET CAP

10.5B

P/E (TTM)

29.2x

FWD P/E

DAY RANGE

$177 – $182

52W RANGE

$142
$218

AI Summary

Stalk
Buy NowMedium

ENSG is forming an early Stage 1 base after a sustained decline, with price now stabilizing above the repaired 9 EMA and 21 EMA and volume contracting post-washout. A high-volume “F” candle on the mid-June low signals initial accumulation, and repeated tests of the rising EMA zone offer favorable pullback entries into the uptrending short-term regime.

  • Q2 revenue $1.4B (+17.3% YoY); EPS $1.92 (+20.8% YoY)
  • Raised 2026 EPS guidance to $7.75–$7.85 amid 84.3% occupancy
  • Medicare and Medicaid rate cuts could pressure reimbursement revenue
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.6B$3.0B$3.7B$4.3B$5.1B
YoY %+9.4%+15.1%+23.3%+14.2%+18.7%
P / Sales1.8x1.8x1.8x1.8x2.0x
EV / Sales2.4x2.4x2.3x2.4x2.6x
Gross Profit, Adj.$468.2M$518.0M$788.1M$883.6M$1.0B
YoY %+14.9%+10.6%+52.2%+12.1%+17.6%
Margin %17.8%17.1%21.1%20.7%20.5%
EV / Gross Profit13.6x14.0x11.1x11.4x12.5x
EBITDA, Adj.$316.4M$359.2M$327.8M$442.4M$529.6M
YoY %+13.9%+13.5%-8.7%+35.0%+19.7%
Margin %12.0%11.9%8.8%10.4%10.5%
EV / EBITDA20.1x20.2x26.7x22.8x24.5x
EBIT$260.5M$296.8M$255.4M$358.3M$425.3M
YoY %+16.7%+14.0%-14.0%+40.3%+18.7%
Margin %9.9%9.8%6.8%8.4%8.4%
EV / EBIT24.4x24.5x34.2x28.2x30.5x
Net Income$194.7M$224.7M$209.4M$298.0M$344.0M
YoY %+14.2%+15.4%-6.8%+42.3%+15.4%
Net Margin7.4%7.4%5.6%7.0%6.8%
EPS (GAAP)$3.42$3.95$3.65$5.12$5.84
YoY %+11.8%+15.5%-7.6%+40.3%+14.1%